Bristol-Myers Squibb Company (BMY)

70.70
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    70.70 - 70.70
Trading near 52-week High

Bristol-Myers Squibb has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

BMY Overview

Prev. Close
67.83
Day's Range
70.7-70.7
Revenue
11.7B
Open
70.7
52 wk Range
57.2-70.7
EPS
3.04
Volume
0
Market Cap
150.98B
Dividend (Yield)
2.16
(3.06%)
Average Volume (3m)
49
P/E Ratio
23.23
Beta
0.423
1-Year Change
7.84%
Shares Outstanding
2,135,255,158
Next Earnings Date
25 Oct 2022
What is your sentiment on Bristol-Myers Squibb?
or
Market is currently closed. Voting is open during market hours.

Bristol-Myers Squibb Company News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Bristol-Myers Squibb Company Analysis

Bristol-Myers Squibb Company Company Profile

Bristol-Myers Squibb Company Company Profile

Employees
30250
  • Type:Equity
  • Market:Peru
  • ISIN:US1101221083
  • S/N:BMY

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically synthesized or small molecule drugs and products produced from biological processes, called biologics. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. It also has a pipeline of investigational medicines designed to target the common mutations associated with oncogenesis, including repotrectinib. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies.

Read More

Analyst Price Target

Average80.70 (+14.13% Upside)
High92
Low63
Price70.71
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong Buy
  • Hello
    0
    • hi
      0